RB 90740

Known as: RB-90740, RB90740 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-1996
02419941996

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Pulse radiolysis was used to generate radicals from one electron reduction of 1,2,4-benzotriazine-1,4-dioxides (derivatives of… (More)
Is this relevant?
1996
1996
RB90740 is the lead compound in a series of fused pyrazine mono-N-oxide bioreductive drugs. Theses agents have potential… (More)
Is this relevant?
1994
1994
PURPOSE To compare the effect on the RIF-1 murine sarcoma of nine bioreductive agents from five different classes when used in… (More)
Is this relevant?
1994
1994
PURPOSE To study the reduction of RB90740 (1), a fused pyrazine mono-N-oxide that has an oxic:hypoxic cytotoxicity ratio of > 10… (More)
Is this relevant?
1994
1994
PURPOSE 1,2-Dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine-5-oxide (RB90740) is a bioreductive… (More)
Is this relevant?
Review
1994
Review
1994
A series of imidazo [1,2-a] quinoxaline mono-N-oxides and their aza- analogues have been synthesized together with analogues… (More)
Is this relevant?